Growth Metrics

Nautilus Biotechnology (NAUT) Change in Account Payables (2020 - 2026)

Nautilus Biotechnology has reported Change in Account Payables over the past 7 years, most recently at $200000.0 for Q1 2026.

  • Quarterly results put Change in Account Payables at $200000.0 for Q1 2026, up 252.67% from a year ago — trailing twelve months through Mar 2026 was $262000.0 (up 132.63% YoY), and the annual figure for FY2025 was -$69000.0, up 88.06%.
  • Change in Account Payables reached $200000.0 in Q1 2026 per NAUT's latest filing, up from $2000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $371000.0 in Q4 2023 and bottomed at -$543000.0 in Q4 2024.
  • Median Change in Account Payables over the past 5 years was $2000.0 (2025), compared with a mean of -$36176.5.
  • The largest annual shift saw Change in Account Payables tumbled 25000.0% in 2022 before it surged 252.67% in 2026.
  • Over 5 years, Change in Account Payables stood at $289000.0 in 2022, then increased by 28.37% to $371000.0 in 2023, then plummeted by 246.36% to -$543000.0 in 2024, then skyrocketed by 100.37% to $2000.0 in 2025, then skyrocketed by 9900.0% to $200000.0 in 2026.
  • Business Quant data shows Change in Account Payables for NAUT at $200000.0 in Q1 2026, $2000.0 in Q4 2025, and -$20000.0 in Q3 2025.